(Q70041708)
Statements
Renewal timing of long-acting depot luteinizing hormone-releasing hormone agonist (Zoladex) is critical in the treatment of hormone-dependent rat prostatic carcinoma (R3327-H) (English)
A A Geldof
H J de Voogt
1 January 1987